Stanniocalcin 2 (STC2) inhibits ferroptosis by activating protein arginine methyltransferase 5 (PRMT5), which increases the expression of SLC7A11, making ESCC resistant to radiotherapy. This evidence concerns the gene STC2 and esophageal squamous cell carcinoma.